Research

The hallucinogen N, N-dimethyltryptamine (DMT) is an endogenous sigma-1 receptor regulator

D Fontanilla, M Johannessen, AR Hajipour… - …, 2009 - science.sciencemag.org

DMT

Added 5 months ago

AR Hajipour

nih.gov

N, N-dimethyltryptamine: an endogenous hallucinogen

SA Barker, JA Monti, ST Christian - International Review of Neurobiology, 1981 - Elsevier

DMT

Added 5 months ago

A dimethyltryptamine-forming enzyme in human blood

RJ Wyatt, JM SAAVEDRA… - American Journal of …, 1973 - Am Psychiatric Assoc

DMT

Added 5 months ago

Juan M. Saavedra

The psychedelic model of schizophrenia: the case of N, N-dimethyltryptamine

K Gillin - 2007 - totseans.com

DMT

Added 5 months ago

totseans.com

Risk assessment of ritual use of oral dimethyltryptamine (DMT) and harmala alkaloids

RS Gable - Addiction, 2007 - Wiley Online Library

DMT

Added 5 months ago

catbull.com

Dose-response study of N, N-dimethyltryptamine in humans: I. Neuroendocrine, autonomic, and cardiovascular effects

RJ Strassman, CR Qualls - Archives of general psychiatry, 1994 - jamanetwork.com

DMT

Added 5 months ago

Endogenous psychoactive tryptamines reconsidered: an anxiolytic role for dimethyltryptamine

MS Jacob, DE Presti - Medical hypotheses, 2005 - Elsevier

DMT

Added 5 months ago

thevespiary.org

Dose-response study of N, N-dimethyltryptamine in humans: II. Subjective effects and preliminary results of a new rating scale

RJ Strassman, CR Qualls, EH Uhlenhuth… - Archives of general …, 1994 - jamanetwork.com

DMT

Added 5 months ago

catbull.com

Effects of 5-methoxy-N, N-dimethyltryptamine on central monoamine neurons

K Fuxe, B Holmstedt, G Jonsson - European Journal of Pharmacology, 1972 - Elsevier

DMT

Added 5 months ago

The globalization of ayahuasca: Harm reduction or benefit maximization?

KW Tupper - International Journal of Drug Policy, 2008 - Elsevier

Ayahuasca

Added 5 months ago

dmt-nexus.me